CA2118752A1 - Method for the Determination of Hemoglobin Adducts - Google Patents

Method for the Determination of Hemoglobin Adducts

Info

Publication number
CA2118752A1
CA2118752A1 CA 2118752 CA2118752A CA2118752A1 CA 2118752 A1 CA2118752 A1 CA 2118752A1 CA 2118752 CA2118752 CA 2118752 CA 2118752 A CA2118752 A CA 2118752A CA 2118752 A1 CA2118752 A1 CA 2118752A1
Authority
CA
Canada
Prior art keywords
hemoglobin
blood sample
determination
adduct
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2118752
Other languages
French (fr)
Other versions
CA2118752C (en
Inventor
Kin-Fai Yip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/077,546 external-priority patent/US6043043A/en
Application filed by Miles Inc filed Critical Miles Inc
Publication of CA2118752A1 publication Critical patent/CA2118752A1/en
Application granted granted Critical
Publication of CA2118752C publication Critical patent/CA2118752C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Disclosed is an improvement to the method of determining the concentration of a hemoglobin adduct in a blood sample by the steps of assaying the blood sample for the total amount of hemoglobin, assaying the blood sample for the hemoglobin adduct, and dividing the hemoglobin adduct concentration by the total hemoglobin concentration. The improvement involves normalizing the measurement of the hemoglobin adduct to the total amount of hemoglobin in the blood sample.
CA002118752A 1993-04-02 1994-03-10 Method for the determination of hemoglobin adducts Expired - Fee Related CA2118752C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4174193A 1993-04-02 1993-04-02
US08/041,471 1993-04-02
US08/077,546 US6043043A (en) 1993-04-02 1993-06-18 Method for the determination of hemoglobin adducts
US08/077,546 1993-06-18

Publications (2)

Publication Number Publication Date
CA2118752A1 true CA2118752A1 (en) 1994-10-03
CA2118752C CA2118752C (en) 2000-12-26

Family

ID=26718468

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002118752A Expired - Fee Related CA2118752C (en) 1993-04-02 1994-03-10 Method for the determination of hemoglobin adducts

Country Status (4)

Country Link
AU (1) AU675289B2 (en)
CA (1) CA2118752C (en)
IL (1) IL109040A (en)
NO (1) NO311543B1 (en)

Also Published As

Publication number Publication date
AU675289B2 (en) 1997-01-30
NO311543B1 (en) 2001-12-03
IL109040A0 (en) 1994-06-24
AU5925594A (en) 1994-10-06
IL109040A (en) 1999-08-17
NO941074D0 (en) 1994-03-24
CA2118752C (en) 2000-12-26
NO941074L (en) 1994-10-03

Similar Documents

Publication Publication Date Title
FI941522A (en) Method for the determination of hemoglobin adducts
EP0385805A3 (en) Signal processing method and apparatus
ES2133019A1 (en) Automated test strip supplying system
DE68910758D1 (en) Determination with affinity substances and HPLC step.
TW369599B (en) A reagent strip and a method for measuring glucose concentration in a sample of whole blood
IL108429A0 (en) Production of an anticoagulant composition
EP0349263A3 (en) Analyzing means and method
AU1245188A (en) Analyte detection in particulate-containing samples
EP0230934A3 (en) Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor.
CA2009813A1 (en) Method for diagnosis of periodontal disease by detection of alanine aminotransferase
EP0909953A3 (en) Method for improving the accuracy of the semi-quantitative determination of analyte in fluid samples
CA2255843A1 (en) Process for the analysis of medical samples containing haemoglobin
CA2051885A1 (en) Apparatus for measuring liquid
CA2118752A1 (en) Method for the Determination of Hemoglobin Adducts
ZA898122B (en) Method for determination of the type and severity of periodontal disease states
AU6186594A (en) Method for non-invasive measurement of concentration of analytes in blood
CA2024052A1 (en) Enzymatic method for determining analyte concentrations
WO1998046993A3 (en) Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor
AU681374B2 (en) Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood
AU2997597A (en) Method and reagent for monitoring blood levels of antiplatelet compounds
IL125880A (en) Method for the determination of analyte concentration in blood
AU5942094A (en) Diagnosis and monitoring of colon cancer patients by measurement of NCA 50/90 in blood
TW373070B (en) Analysis element and method for preparing the same
Zhao A Simplified Method for the Photometric Determination of Trace Elements
Zhang Determination of Aluminium in Copper-Base Alloy by Reduced Pressure Ion Exchange Chromatography--Spectrophotometry

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20070312